-

Program

Sunday, 7 October 2012
 

18:30 Opening lecture

to be announced

to be announced

19:30 Welcome Aperitif

20:00   Dinner

 

Monday, 8 October 2012
 

Hepatitis E

08:30- 13:00   Morning session: plenary lectures

Chair:

M. A. Purdy,  Centers for control and prevention, Atlanta, US

 

Current perspectives on HEV evolution

M. A. Purdy, Centers for control and prevention, Atlanta, US

Hepatitis E virus: replication and molecular biology

X.-J. Meng, Virginia Polytechnic Institute and State University, Blacksburg, US

Hepatitis E virus: neutralizing sites, diagnosis and protective immunity

J. Zhang, National Institute of Diagnostics and Vaccine Development in Infectious Diseases, Xiamen, China

HEV chronicity and transplants, HEV treatment

J. Izopet, CHU Rangueil, Toulouse, FR

13:00 Lunch

14:30 Afternoon session: abstract presentations and discussion around the poster boards
 



Tuesday, 9 October 2012

 

Hepatitis B

08:00- 12:30 Morning session: plenary lectures

Chairs:                                                                                                                                                     &

P. Arbuthnot, University of the Witwatersrand, Johannesburg, South Africa

F. Zoulim, INSERM U1052 University of Lyon 1, Lyon, FR

 

HBV replication and viral entry

S. Urban, University Hospital of Heidelberg, Heidelberg, DE

Insight from experimental models and clinical studies

F. Zoulim, INSERM U1052/University of Lyon 1, Lyon, FR

Novel insight in HBV - host interactions

U. Protzer, Technische Universität München / Helmholtz Zentrum München, München, DE

RNA interference-based treatment of HBV infection

P. Arbuthnot, University of the Witwatersrand, Johannesburg, South Africa

12:30 Lunch

14:00 Day Trip
 

 

Wednesday, 10 October 2012

 

Hepatitis C 

08:30-13:00 Morning session: plenary lectures

Chairs:

T. F. Baumert, T. F. Baumert, INSERM 748 University of Stasbourg, FR

J. A. McKeating, College of Medical and Dental Sciences/University of Birmingham, Birmingham, UK

 

Molecular mechanisms of HCV entry

J. A. McKeating, College of Medical and Dental Sciences/University of Birmingham, Birmingham, UK

Clinical implications of HCV entry for liver disease and antiviral treatment

T. F. Baumert, INSERM 748 University of Stasbourg, FR

HCV treatment - perspectives and future challenges

H. Wedemeyer, Hannover Medical School, Hannover, DE

Host factors for viral HCV replication and assembly

V. Lohmann, University of Heidelberg, Heidelberg, DE

13:00 Lunch

14:30 Afternoon session: abstract presentations and discussion around the poster boards

 

Thursday, 11 October 2012

Bus leaving in Front of the Hotel Victoria to the Geneva airport early morning
 


 

Search:
 inside this site:
   
   
 Go
 
rss/atom
CH-1015 Lausanne  - Switzerland  -  Tel. +41 21 69256 00  -  Fax +41 21 69256 05
Swiss University